KALEIDA HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1998-01-01
- Employees
- -
- Market Cap
- -
Lovaza's Effect on Clopidogrel in a Neuro Population
Early Phase 1
- Conditions
- Ischemic StrokeTransient Ischemic Attack
- Interventions
- Dietary Supplement: omega-3 polyunsaturated fatty acids (Lovaza)
- First Posted Date
- 2012-02-06
- Last Posted Date
- 2012-02-06
- Lead Sponsor
- Millard Fillmore Gates Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01526824
- Locations
- 🇺🇸
Millmore Fillmore Gates Hospital, Buffalo, New York, United States
© Copyright 2025. All Rights Reserved by MedPath